The DOI matches its Crossref record.
Molecular Mechanisms Underlying the Dedifferentiation Process of Isolated Hepatocytes and Their Cultures
Abstract
Primary hepatocytes and their cultures are a simple but versatile, well-controlled, and relatively easy to handle in vitro system that is well-accepted for investigating xenobiotic biotransformation, enzyme induction and inhibition, and (biotransformation-mediated) hepatotoxicity. In addition, hepatocyte cultures have proven to be valuable tools in the study of liver physiology, viral hepatitis, and liver regeneration and are proposed as an alternative to orthotopic liver transplantation. It has been observed, however, that a number of liver-specific functions are progressively lost with time when hepatocytes are isolated and cultivated. These phenotypic changes are primarily the result of fundamental changes in gene expression concomitant with a diminished transcription of the relevant liver-specific genes, and can be interpreted as a 'dedifferentiation' of the isolated hepatocytes. Ischemia-reperfusion stress induced during the isolation process, disruption of the normal tissue architecture, as well as an adaptation to the in vitro environment are underlying factors and will be extensively discussed. A detailed description of the regulation of the hepatocyte phenotype in vivo in the first section of this review will help to understand the effect of these factors on hepatocyte gene expression. Although different approaches, mainly mimicking the in vivo hepatocyte environment, have been succesfully used to prevent or slow down the dedifferentiation of primary hepatocytes in m…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Loss of differentiation of primary human hepatocytes (PHHs) ex vivo is a known problem of in vitro liver models.”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Elaut et al., 2006[10]
In the citing paper
“A dedifferentiation-associated downregulation of albumin, the liver-enriched transcription factor HNF4A and its downstream targets in the cytochrome P450 enzyme group in primary hepatocyte cultures is well described (Elaut et al., 2006[10]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Elaut et al., 2006[10]
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Items 201–292 of 292
Prince, J. M., Yoram Vodovotz, B., Baun, M., Monga, S. P., Billiar, T. R., & Gerlach, J. C. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0256 · Cited by 7
Raut, A., & Khanna, A. (2016) · Hepatology Research · doi:10.1111/hepr.12820 · Cited by 7
Yip, C. H., Chen, A. D., Wong, Y. H., & Chan, B. P. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121367 · Cited by 7
Differentiation-Promoting Medium Additives for Hepatocyte Cultivation and Cryopreservation
Gouliarmou, V., Pelkonen, O., & Coecke, S. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-2074-7_10 · Cited by 7
Henkens, T., Vinken, M., Vanhaecke, T., & Rogiers, V. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.04.014 · Cited by 7
Self-citationIrani, K., Pomerantseva, I., Hart, A. R., Sundback, C. A., Neville, C. M., & Vacanti, J. P. (2009) · Artificial Organs · doi:10.1111/j.1525-1594.2009.00784.x · Cited by 7
Evaluation of promoter strength in mouse and rat primary hepatocytes using adenovirus vectors
ARITA, E., Kondoh, M., Isoda, K., NISHIMORI, H., Yoshida, T., Mizuguchi, H., & YAGI, K. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.03.013 · Cited by 7
Adam, A. A. A., Jongejan, A., Moerland, P. D., van der Mark, V. A., Elferink, R. P. J. O., Chamuleau, R. A. F. M., & Hoekstra, R. (2020) · Cytotechnology · doi:10.1007/s10616-020-00384-w · Cited by 6
Yang, Q., & Li, A. P. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000424 · Cited by 6
Chi, K. Y., & Kim, J. (2022) · Organoid · doi:10.51335/organoid.2022.2.e6 · Cited by 6
Effects of Membrane Molecular Weight Cutoff on Performance of a Novel Bioartificial Liver
Shi, X., Zhang, Y., Han, B., Gu, J., Chu, X., Xiao, J., Ren, H., Tan, J., & Ding, Y. (2011) · Artificial Organs · doi:10.1111/j.1525-1594.2011.01201.x · Cited by 6
Sumii, T., Nakano, Y., Abe, T., Nakashima, K., Sera, T., & Susumu, K. U. D. O. (2016) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-016-9999-y · Cited by 6
Dynamic regulatory module networks for inference of cell type–specific transcriptional networksPreprint
Siahpirani, A. F., Knaack, S., Chasman, D. A., Seirup, M., Sridharan, R., Stewart, R. M., Thomson, J. L., & Roy, S. (2022) · Genome Research · doi:10.1101/gr.276542.121 · Cited by 6
Hepatic Spheroids for Long-Term Toxicity Studies
Jakubek, L. M., Ulinski, G., Leite, D., Slavsky, M., Rajanna, S., Morelli, J. K., Kelly, M., Dwyer, J., Fitzgerald, M., Piepenhagen, P. A., et al. (2016) · Applied In Vitro Toxicology · doi:10.1089/aivt.2016.0016 · Cited by 5
Ditewig, A. C., Cugier, D. J., Liguori, M. J., Yang, Y., & Blomme, E. A. G. (2013) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2013.796031 · Cited by 5
Epigenetic Modifications as Antidedifferentiation Strategy for Primary Hepatocytes in Culture
Bolleyn, J., Fraczek, J., Rogiers, V., & Vanhaecke, T. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-2074-7_14 · Cited by 5
Self-citationMegahed, F. A. K., Zhou, X., Sun, P., & Elmaghrabi, M. M. (2021) · Egyptian Liver Journal · doi:10.1186/s43066-021-00084-w · Cited by 5
Ramella Gal, I., Arez, F., Correia, I. P., Domenici, G., Fernandes, S., Silva, G., Saldanha, I., Duarte, N., Freitas, C., Alves, P. M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-31044-8 · Cited by 4
Faria, B. Q., Calixto, P. S., Picheth, G., Ferreira, L. M., Rego, F. G. D. M., Guerra, J. F. D. C., & Sari, M. H. M. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111717 · Cited by 4
Afshari, A., Azarpira, N., & Pakbaz, S. (2025) · BMC Molecular and Cell Biology · doi:10.1186/s12860-025-00534-y · Cited by 4
Minuth, W. W., & Denk, L. (2012) · Clinical and Translational Medicine · doi:10.1186/2001-1326-1-22 · Cited by 4
Nudischer, R., Renggli, K., Bertinetti‐Lapatki, C., Hoflack, J.-C., Flint, N. A., Sewing, S., Pedersen, L., Schadt, S., Higgins, L. G., Vardy, A., et al. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa076 · Cited by 5
Fibroblast Growth Factor 19 Induced Changes in Non-malignant Cholangiocytes
Yang, J., Sontag, D., Kung, S., & Minuk, G. Y. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00087 · Cited by 4
Moreno, D., Balasiddaiah, A., Lamas, Ó., Duret, C., Neri, L., Guembe, L., Galarraga, M., Larrea, E., Daujat‐Chavanieu, M., Muntané, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074948 · Cited by 4
Seidemann, L., Prinz, S., Scherbel, J.-C., Götz, C., Seehofer, D., & Damm, G. (2023) · IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund · doi:10.17179/excli2022-5459 · Cited by 3
Lyu, C., Yang, L., & Chen, S. (2025) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101666 · Cited by 3
Neo, S., MAKIISHI, E., Fujimoto, A., & Hisasue, M. (2020) · Journal of Veterinary Medical Science · doi:10.1292/jvms.20-0320 · Cited by 3
Imai, T., Ishigamori, R., Naruse, M., Ochiai, M., Maru, Y., Hippo, Y., & Totsuka, Y. (2024) · The Journal of Toxicological Sciences · doi:10.2131/jts.49.425 · Cited by 3
Engineering a three-dimensional liver steatosis model
Johnston, E. K., Zhou, F., Soto–Gutiérrez, A., Taner, C. B., Cook, K. E., Liu, Y., & Abbott, R. D. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167888 · Cited by 3
Moreno, D., Neri, L., Vicente, E., Vales, Á., & Aldabe, R. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6506-9_12 · Cited by 3
Luce, E., Steichen, C., Abed, S., Weber, A., Leboulch, P., Maouche-Chrétien, L., & Dubart‐Kupperschmitt, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810861 · Cited by 3
Testroet, E. D., Choudhary, S., Choudhary, R. K., Beitz, D. C., & Du, . (2022) · JDS Communications · doi:10.3168/jdsc.2022-0263 · Cited by 3
Low-Density Lipoprotein Uptake Demonstrates a Hepatocyte Phenotype in the Dog, but Is Nonspecific
Gow, A. G., Muirhead, R. H., Hay, D. C., & Argyle, D. J. (2015) · Stem Cells and Development · doi:10.1089/scd.2015.0054 · Cited by 3
Vinken, M. (2011) · Pharmaceutica Analytica Acta · doi:10.4172/2153-2435.1000101e · Cited by 3
Self-citationPredictive Toxicology: Latest Scientific Developments and Their Application in Safety Assessment
Armstrong, D., Li, S., Frieauff, W., Martus, H. ‐., Reilly, J., Mikhailov, D., Whitebread, S., & Urbán, L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12367-4 · Cited by 3
Nanoengineered Biomaterials for the treatment of liver diseases
Ortega‐Ribera, M., Yeste, J., Villa, R., & Gracia‐Sancho, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813355-2.00018-1 · Cited by 4
Phenotypic Assessment of Liver-Derived Cell Cultures during in vitro Expansion
Iacob, R. A., Herlea, V., Savu, L., Florea, I. R., Ilie, V., Terinte‐Balcan, G., Gherghiceanu, M., Uta, M., Popa, C., Iacob, S., et al. (2021) · Regenerative Medicine · doi:10.2217/rme-2020-0093 · Cited by 3
"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Ortega‐Prieto, A. M., Skelton, J. K., Cherry, C., Briones-Orta, M. A., Hateley, C. A., & Dorner, M. (2019) · Journal of Visualized Experiments · doi:10.3791/58333-v · Cited by 3
Fatouh, A. M., Adly, M. E., Taweel, M. M. E., & Tawfik, M. A. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108345 · Cited by 2
The modern creation technologies of implanted bioartificial liver
Dolgikh, M. S. (2010) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20105604425 · Cited by 2
Perfilova, V. N. (2023) · Safety and Risk of Pharmacotherapy · doi:10.30895/2312-7821-2023-379 · Cited by 2
Kammerer, S., & Küpper, J. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189321 · Cited by 2
Expression profiling of adhesion proteins during prenatal and postnatal liver development in rats
Yousaf, M., Tayyeb, A., & Ali, G. (2017) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s139497 · Cited by 2
Dash, A., & Proctor, W. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813671-3.00006-2 · Cited by 3
Miller, J. G. P., Jamwal, A., Ilnytskyy, Y., Hontela, A., & Wiseman, S. B. (2020) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2020.100744 · Cited by 2
Proteomics informed investigation of human hepatocytes and liver tissue
Handin, N. (2021) · Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy · doi:10.33063/diva-446954 · Cited by 3
Henkens, T., Snykers, S., Vinken, M., Fraczek, J., Lukaszuk, A., Tourwé, D., Verheyen, G. R., Gompel, J. V., Vanparys, P., Rogiers, V., et al. (2010) · Toxicology in Vitro · doi:10.1016/j.tiv.2010.09.013 · Cited by 2
Self-citationMulti-omics of sorafenib responsiveness in HCC patientsPreprint
Dazert, E., Boldanova, T., Ng, C. K. Y., Colombi, M., Wieland, S. F., Rosenberger, G., Marass, F., Piscuoglio, S., Beerenwinkel, N., Terracciano, L., et al. (2025) · medRxiv · doi:10.1101/2025.07.15.25331324 · Cited by 2
The modern technologies for creation of implanted bioartificial liver
Dolgikh, M. S. (2010) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750810020058 · Cited by 1
Cell culture methods for acute toxicology testing
Barile, F. A. (2013) · CRC Press eBooks · doi:10.1201/b15319-21 · Cited by 1
Beuke, K., Schildberg, F. A., Pinna, F., Albrecht, U., Liebe, R., Bissinger, M., Schirmacher, P., Dooley, S., Bode, J. G., Knolle, P. A., et al. (2017) · FEBS Journal · doi:10.1111/febs.14022 · Cited by 1
Banan, B., & Chapman, W. C. (2017) · Current Transplantation Reports · doi:10.1007/s40472-017-0137-x · Cited by 1
Goda, K., & Masuyama, T. (2020) · Fundamental Toxicological Sciences · doi:10.2131/fts.7.153 · Cited by 1
Gotoh, Y., Niimi, S., Tamura, K., Akahira, R., & Inamura, M. (2020) · Bio-Medical Materials and Engineering · doi:10.3233/bme-201078 · Cited by 1
Advances in Micro-Bioreactor Design for Organ Cell Studies
Mandenius, C. (2018) · MDPI eBooks · doi:10.3390/books978-3-03897-232-7 · Cited by 1
Uchea, C. (2013) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 1
In Vitro Models for the Prediction of Drug‐Induced Liver Injury in Lead Discovery
Moulin, F., & Flint, O. P. (2015) · Methods and principles in medicinal chemistry · doi:10.1002/9783527673643.ch07 · Cited by 1
Application of Pluripotent Stem Cells in Drug‐Induced Liver Injury Safety Assessment
Pridgeon, C. S., Zhang, F., Heslop, J. A., Nugues, C., Kitteringham, N. R., Park, B. K., & Goldring, C. E. (2016) · Wiley eBooks · doi:10.1002/9781119053248.ch21 · Cited by 1
Validation of a library of cGMP-compliant human pluripotent stem cell lines for use in liver therapyPreprint
Blackford, S. J. I., Ng, S. S., Segal, J. M., King, A., Moore, J. C., Sheldon, M., Ilić, D., Dhawan, A. K., Mitry, R. R., & Rashid, S. T. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/298760 · Cited by 1
Gineste, C., Youhanna, S. C., Vorrink, S. U., Henriksson, S., Hernández, A., Cheng, A. J., Chaillou, T., Buttgereit, A., Schneidereit, D., Friedrich, O., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.29.437546 · Cited by 1
Liver cell types derived from pluripotent stem cells
Harrison, S. P. (2014) · Research Explorer (The University of Manchester)
Glycogen Synthase Kinase 3 (GSK-3) involvement in regulation of mouse embryonic stem cell fate
Sanchez-Ripoll, Y. (2011) · The University of Bath Online Publications Store (The University of Bath)
Vildhede, A. M. (2015) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
In vitro-Zytotoxizitätsanalyse mit humanen Primärhepatozyten
Larson, B., Moeller, T., Cameron, G. W. W., & Mailliet, J. (2014) · BIOspektrum · doi:10.1007/s12268-014-0519-x
The Impact of a 3-Dimensional Human Liver Microtissue Model on Long-term Hepatotoxicity Studies
Larson, B., Banks, P., & Moeller, T. A. (2014)
Solon, T., & Andrianarijaona, I. A. (2013)
The Impact of Tissue Engineering in Pediatric Surgery
Grikscheit, T. C., & Vacanti, J. P. (2006) · Elsevier eBooks · doi:10.1016/b978-0-323-02842-4.50006-1
Impact of Tissue Engineering in Pediatric Surgery
Pryor, H. I., Hoganson, D. M., & Vacanti, J. P. (2012) · Elsevier eBooks · doi:10.1016/b978-0-323-07255-7.00003-9
Barile, F. A. (2013) · CRC Press eBooks · doi:10.1201/b15319-15
Rogiers, V., Vinken, M., Snykers, S., Henkens, T., Fraczek, J., Rop, E. D., Kock, J. D., Doktorova, T. Y., Lukaszuk, A., Tourwé, D. A., et al. (2008) · VUBIR (Vrije Universiteit Brussel)
Self-citationCell Culture Methods for Acute Toxicology Testing
(2007) · CRC Press eBooks · doi:10.1201/9781420008326.ch13
Characterisation of inducible proteins in the HepG2 cell line proteome
Ellero, A. A. (2022) · UpSpace Institutional Repository (University of Pretoria) · doi:10.6019/pxd024353
Off-the-Shelf Engineered Liver Tissue Reverses Acute Liver Failure Without ImmunosuppressionPreprint
Raggi, C. C., Lapierre, P., M’Callum, M.-A., Pham, Q. T., Selleri, S., Paun, R. A., Baratang, N., Mangahas, C. L., Benabdallah, B., Moquin‐Beaudry, G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.08.680796
Plasticity of Cancer Stem Cells
Li, Z. (2011) · Springer eBooks · doi:10.1007/978-94-007-2801-1_26
Huang, Y.-H., Yamashita, T., & Sudo, R. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202504378
Cell polarity in hepatic cells physiopathology
Akkari, L. (2010) · theses.fr (ABES) · doi:10.70675/50d0b5fez8356z488fzb2b0z029ae5e17d3a
Silva, F. D. (2018) · theses.fr (ABES) · doi:10.70675/a1ef7558z4d24z4e76zb646zb00718717192
Mise au point et développement de modèles hépatiques complexes par bio-impression 3D
Cuvellier, M. (2020) · theses.fr (ABES) · doi:10.70675/b6c577cdzcaffz460az8214z9681de8f3941
Ando, H., Matsuo, C. N. A., Akagi, S., Tajima, K., Takata, H., Serizawa, R., Matsushima, T., Kusano, T., & Ishida, T. (2026) · Biomedical Materials · doi:10.1088/1748-605x/ae7243
In Vitro Three-Dimensional Human Liver Model for Drug-Induced Liver and Bile Duct Injury Prediction
Fu, X., Hu, J., Jiang, X., Sun, Y., Xiang, W., Kuang, R., Kang, H., He, L., & Sang, J. (2026) · Toxics · doi:10.3390/toxics14080724
Hartauer, M., Geffert, R. M., Ohri, S., Snyder, J. R., Tiley, J. B., Fallon, J. K., Ho, H. S. S., Cirit, M., Rajan, S. A. P., & Brouwer, K. L. R. (2026) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70418
Vincze, K., Varga, N., Tóth, S., Kis, A. K., Béres, R., Réthelyi, J., Veréb, Z., Erdei, Z., Sarkadi, B., & Apáti, Á. (2026) · Pathology & Oncology Research · doi:10.3389/pore.2026.1612490
Caldovic, L. (2026) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2026.110241
Santamaria, A., Gilles, L. V., Kröhn, M., Renz, L., Boerger, L., Walter, K. A., Moosburner, S., Sauer, I. M., Pratschke, J., Raschzok, N., et al. (2026) · Bioengineering · doi:10.3390/bioengineering13111274
Metadata
- Authors
- Elaut, G., Henkens, T., Papeleu, P., Snykers, S., Vinken, M., Vanhaecke, T., & Rogiers, V.
- Affiliations
- Vrije Universiteit Brussel (BE)
- Venue
- Current Drug Metabolism
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2006-08-01
- Volume
- 7
- Issue
- 6
- Pages
- 629-660
- ISSN
- 1389-2002 (ISSN-L)
- OpenAlex
- W2150031244
- Cited by
- 292
- References
- 0
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 6 · 2023: 9 · 2022: 18 · 2021: 26 · 2020: 20 · 2019: 16 · 2018: 21 · 2017: 16 · 2016: 16 · 2015: 13 · 2014: 14 · 2013: 17 · 2012: 16
- FWCI
- 9.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Drug Metabolism (publishedVersion)
- PubMed (publishedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Keywords
- hepatocyte dedifferentiation, primary hepatocytes, hepatocyte culture, hepatocyte phenotype, gene expression, hepatocyte isolation, hepatocyte-like cells, hepatic progenitor cells, xenobiotic metabolism, liver regeneration
- MeSH terms
- Animals, Cell Communication, Cell Differentiation, Cells, Cultured, Extracellular Matrix, Gene Expression Regulation, Humans, Nitric Oxide, Phenotype, Eicosanoids, Cytokines, Apoptosis, Reactive Oxygen Species, Hepatocytes, Reactive Nitrogen Species, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
